What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Roche’s CT-388 shows promising results in Phase I trial for obesity and Type 2 diabetes treatment Roche has announced positive outcomes from the Phase I clinical trial of CT-388, a novel dual GLP-1/GIP receptor… byPallavi MadhirajuMay 19, 2024